Oncology
肿瘤科 · Shanxian Central Hospital, Heze
Established in 1989, this department provides comprehensive cancer care using advanced radiotherapy and chemotherapy. Equipment includes an accelerator, X-knife, cobalt-60 unit, and high-dose afterloading machine. The team treats various tumors, including lymphoma, breast, colorectal, esophageal, and lung cancers. Services include stereotactic radiotherapy, percutaneous needle biopsies, and interventional embolization. Chemotherapy protocols involve high-dose cisplatin and methotrexate. The department emphasizes combined treatment strategies for advanced cases, metastases, and post-operative recurrences to improve quality of life. It manages conditions across digestive, respiratory, and genitourinary systems, offering options for patients who are unable or unwilling to undergo surgery.
Conditions and treatments
- Stereotactic radiotherapy (X-knife)
- Chemotherapy (high-dose cisplatin and methotrexate)
- Percutaneous needle biopsy (lung and liver)
- Interventional embolization therapy
- Treatment of lymphoma, breast, colorectal, esophageal, and lung cancers
- Management of metastatic and recurrent tumors
Key facts
- Founded in 1989
- 26 regular beds
- Approximately 8,000 late-stage tumor cases treated
Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.
| Specialty | Medical Oncology |
|---|---|
| Doctors listed | 9 |
| Chief physicians | — |
Senior doctors
Chief and associate chief physicians listed for this department on public doctor-listing platforms (2025–2026).
Associate chief physicians
- Yanfeng Liu刘岩峰
- Kefen Liu刘克分
- Jungong Wei魏军功
We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.
Need a specialist's opinion?
Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.
Contact us